Healthcare, Lifestyle, Local News, Science

UroGen announces results from subgroup analyses of the pivotal ENVISION trial evaluating impact of baseline tumor burden and focality on response to UGN-102

Results presented at the American Society of Clinical Oncology’s Genitourinary Cancers Symposium (ASCO GU 2025) Treatment with UGN-102 resulted in durable complete response (CR) rates across subgroups with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC) CR rates were: 82.8% for patients

Business, Energy & Power, Lifestyle, Science

Pioneer Power renews on-site power service agreement with large US retailer for estimated $2M in annual revenue over three years

FORT LEE, N.J. — (BUSINESS WIRE) — Pioneer Power Solutions, Inc. (Nasdaq: PPSI) (“Pioneer” or the “Company”), a leader in the design, manufacture, service and integration of distributed energy resources, power generation equipment and mobile electric vehicle (“EV”) charging solutions, on Thursday